Clinical and Biological Characteristics of Hidradenitis Suppurativa
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Hidradenitis Suppurativa. Basic parameters: from 13 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Primary outcome measures
- The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa. [Time frame: 2016-2026]
Secondary outcome measures (1)
- Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy. [Time frame: 2016-2026]
Eligibility criteria
Hidradenitis Suppurativa Patients
Inclusion criteria
- Age 13 years or older
- Diagnosis of HS clinically-confirmed by a physician
Exclusion criteria
1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Healthy Volunteer
Inclusion criteria
- No history of chronic skin conditions
- No recent history of antibiotic use
Exclusion criteria
1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- University of California, San Francisco — San Francisco
Identifiers
NCT: NCT03967600 · 16-19770